A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021
Clinical trial NCT06089733 · COMPLETED
Trial details
- NCT number
- NCT06089733
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-11
- Primary completion
- 2023-08-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.